Waystar Holding Corp

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Waystar reports strong Q3 earnings, raises 2024 guidance confidently

Waystar's Q3 2024 performance reflects robust revenue growth, profitability, and client engagement, supported by cybersecurity initiatives and network enhancements.
The company's raised revenue guidance and strong EBITDA margins underscore confidence in future prospects and potential for sustained growth.
While facing challenges in evolving market dynamics, Waystar has opportunities to drive innovation, strengthen client relationships, and capitalize on its positive momentum.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Waystar Holding Corp. engages in the provision of healthcare organizations with mission-critical cloud software that simplifies healthcare payments. Its enterprise-grade platform streamlines the complex and disparate processes healthcare provider clients must manage to be reimbursed correctly, while improving the payments experience for providers, patients, and payers. The company was founded in 2000 and is headquartered in Lehi, UT.

Waystar Holding Corp., a healthcare payments software company, on Tuesday said it plans to offer 45 million shares at an estimated price range of $20 to $23 a share in its upcoming initial public offering. At the midpoint of the range, Waystar's IPO will raise about $967.5 million with underwriters JPMorgan, Goldman Sachs and Barclays.

Private equity-backed Waystar seeks to raise about $1 billion in IPO

Healthcare payments company Waystar said on Tuesday it was targeting a valuation of up to $3.83 billion in its initial public offering in the United States.

Waystar aims up to $3.83 bln valuation in US IPO

LEHI, Utah and LOUISVILLE, Ky. , May 28, 2024 /PRNewswire/ -- Waystar Holding Corp. ("Waystar") today announced the launch of its initial public offering of 45,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC").

Waystar Announces Launch of Initial Public Offering

Centurion Acquisition Corp

Bowhead Specialty Holdings Inc

Tempus AI Inc

Specialty property & casualty insurer Bowhead Specialty Holdings priced its upsized IPO at the top of the range to raise $128 million at a $551 million market cap. Three IPOs submitted initial filings this past week. The May IPO market is expected to end on a quiet note, with no IPOs currently scheduled for the short Memorial Day week.

U.S. IPO Weekly Recap: Specialty Insurer Bowhead Sole IPO To Debut As More Names Join The Pipeline

Waystar is reportedly planning to launch its initial public offering (IPO) in early June, seeking a valuation of $5 billion or $6 billion. The healthcare payments company will begin its roadshow pitch to investors later in May, the Wall Street Journal (WSJ) reported Tuesday (May 14), citing unnamed sources.

Report: Waystar Plans to Launch IPO in Early June

The private equity-backed company is eyeing a June stock-market debut.

Payments-Company Waystar Plans to Restart IPO Pitch

Boundless Bio Inc

IB Acquisition Corp

Alta Global Group Ltd

Mobile-Health Network Solutions

Netclass Technology Inc

U-BX Technology Ltd

ZEEKR Intelligent Technology Holding Ltd

Three IPOs and one SPAC debuted this past week, while three IPOs submitted initial filings - Boundless Bio, U-BX Technology, Alta Global, and IB Acquisition, respectively. Three IPOs submitted initial filings this week - Marex Group, Reitar Logtech and NetClass.

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

MACHESNEY PARK, Ill.--(BUSINESS WIRE)--Experity announced complete migration of urgent care practices to Waystar in response to a recent incident at Change Healthcare (Optum).

Experity Completes Migration of Clients to Waystar

Elevai Labs Inc

Smith Douglas Homes Corp

Skincare company Elevai Labs priced at the low end to raise $6 million at a $69 million market cap. Colombier Acquisition Corp. II upsized to raise $150 million. Several issuers are primed for post-Thanksgiving launches.

U.S. IPO Weekly Recap: IPO Market Sees A Little Activity In The Short Holiday Week

Birkenstock Holding Plc

Instacart (Maplebear Inc.)

Klaviyo, Inc. 

Neumora Therapeutics Inc

VinFast Auto Ltd

The U.S. initial public offering calendar is empty this holiday-shortened week, but some recent additions to the pipeline suggest December could be livelier and welcome deals from some profitable, decent-sized companies.

IPO pipeline welcomes some profitable companies, raising hopes for a rebound

DDC Enterprise Ltd

Global Lights Acquisition Corp

Richtech Robotics Inc

Signing Day Sports Inc

Shimmick Corp

Four smaller IPOs priced this past week, joined by one SPAC. The biggest news came from the pipeline, with product assessment services provider UL Solutions filing for an estimated $1 billion IPO, followed by a sizable filing from metabolic disease biotech Carmot Therapeutics. The IPO calendar looks quiet for the Thanksgiving week, although some small issuers may join last minute.

U.S. IPO Weekly Recap: Smaller Deals Slip Through The IPO Window Before The Thanksgiving Break

Alpha Technology Group Ltd

Bloomz Inc

Hamilton Insurance Group Ltd

Renaissance IPO ETF

Renaissance International IPO ETF

Kenvue

Lexeo Therapeutics Inc

Neo-Concept International Group Holdings Ltd

Pineapple Financial Inc

Palantir Technologies

Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&P 500 was up 14.0%. Renaissance Capital's IPO ETF tracks Renaissance IPO Index, and top ETF holdings include Palantir Technologies and Kenvue.

U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO

Healthcare payments firm Waystar's plans to go public are reportedly on hold. The company had planned to begin an investors roadshow in advance of an initial public offering (IPO) this week, but will now wait to do so until December at the earliest, the Wall Street Journal (WSJ) reported Tuesday (Oct.

Waystar Listing In Limbo Amid Unhealthy IPO Market

Healthcare software company Waystar, which was set to launch its initial public offering roadshow to pitch investors this week, has now delayed it until December at the earliest, the Wall Street Journal reported on Tuesday.

Waystar delays IPO until December or 2024 - Wall Street Journal

Waystar was set to launch its roadshow to pitch investors this week, but now is not expected to do so until December at the earliest, people familiar with the matter said. T

Waystar IPO Delayed Until December or 2024

Abivax SA

Correlate Energy Corp.

J-Long Group Ltd

Mach Natural Resources LP

iShares MSCI Global Impact ETF

Northann Corp

Webuy Global Ltd

Both the calendar and the pipeline saw some movement this past week. Two large IPOs launched, one of which also priced, and two sizable deals submitted new filings. Eight IPOs submitted initial filings, led by three sizable names. Mach Natural Resources is currently the only IPO scheduled for the week ahead, although some small issuers may join the calendar late.

U.S. IPO Weekly Recap: Big Launches And New Filings Keep The IPO Market Moving

Healthcare payments are awash in paper, marked by inefficiencies, creaky legacy systems and manual processes. Waystar leverages a cloud-based platform to improve what it terms “the administrative headwinds faced by providers.

Waystar Sees $15 Billion Market for Simplifying Healthcare Payments as It Preps for IPO

Waystar Holding Corp. has filed for a $100 million IPO to raise capital for debt repayment, although the final figure may differ. The company provides a cloud-based software system for healthcare payment processing. Waystar's revenue growth is slowing, but its operating results are improving.

Waystar Holding Corp. Begins $100 Million IPO Rollout

Waystar Technologies, the healthcare payments start-up, is readying to IPO after publicly disclosing its filing for a U.S. stock market flotation, while also revealing an increase in quarterly sales.

Healthcare payments group Waystar set to IPO in New York

Healthcare payments startup Waystar Technologies on Monday made public its filing for a U.S. stock market flotation and revealed a rise in quarterly sales. Reuters reported in August that Waystar was eyeing an initial public offering (IPO) that could value it at up to $8 billion.

Healthcare payments startup Waystar makes IPO filing public

LEHI, Utah and LOUISVILLE, Ky. , Oct. 16, 2023 /PRNewswire/ -- Waystar Technologies, Inc., a provider of leading healthcare payment technology, today announced that its parent company, Waystar Holding Corp., has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of the parent company's common stock.

Waystar Announces Public Filing of Registration Statement for Proposed Initial Public Offering

News for Waystar Holding Corp Stock (WAY)